Women's preferences for prevention of bone loss
Liana Fraenkel1, Florina Constantinescu, Mayra Oberto-Medina
1Section of Rheumatology, Department of Medicine, Yale University School of Medicine, New Haven, Connecticut 06520-8031, USA. liana.fraenkel@yale.edu
Objective:
Despite the serious consequences of osteoporosis, few women use pharmacologic measures to prevent postmenopausal bone loss. We used an interactive computerized questionnaire to examine women's preferences for prevention of osteoporosis.
Methods:
We administered a choice-based conjoint analysis survey (CBCA) to consecutive early postmenopausal women in a shopping center. The questionnaire was constructed to measure preferences for pharmacologic and nonpharmacologic measures to prevent postmenopausal bone loss. Women were also given the option of choosing "none," i.e., to defer or refuse all options. Utilities were calculated based on a Hierarchical Bayes model using Monte Carlo-Markov chain algorithms. We performed simulations based on women's values for specific treatment characteristics to estimate choice.
Results:
A total of 212 women agreed to complete the survey (42% participation rate). Between 18% and 47% of the women surveyed (mean age 52+/-5 yrs) were predicted to choose once-weekly medications to prevent postmenopausal bone loss, assuming treatment confers an absolute lifetime risk reduction in fractures of at least 10%.
Conclusion:
In this CBCA survey, which derived preferences based on how women make tradeoffs between specific treatment characteristics, a significant percentage of women were willing to use once-weekly medications to prevent postmenopausal bone loss.
Related Concept Videos
01:40Bone Remodeling
01:29Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
01:31Essential Minerals for Bone Health
Calcium and Phosphorus
Calcium is a critical component of bones, especially in the form of calcium phosphate and calcium carbonate. Since the body cannot make calcium, it must be obtained from the diet. However, calcium cannot be absorbed from the small intestine without...
01:17Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
01:25Role of Vitamins in Maintaining Bone Health
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
01:27Urinary Tract Calculi IV: Nutrition Therapy and Prevention